Acute disseminated encephalomyelitis after SARS-CoV-2 infection

Neurol Neuroimmunol Neuroinflamm. 2020 Jun 1;7(5):e797. doi: 10.1212/NXI.0000000000000797. Print 2020 Sep.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Ageusia / etiology
  • Ageusia / physiopathology
  • Brain / diagnostic imaging
  • COVID-19
  • Coronavirus Infections / complications*
  • Encephalomyelitis, Acute Disseminated / diagnostic imaging
  • Encephalomyelitis, Acute Disseminated / etiology*
  • Encephalomyelitis, Acute Disseminated / physiopathology
  • Encephalomyelitis, Acute Disseminated / therapy
  • Evoked Potentials, Visual
  • Female
  • Glucocorticoids / therapeutic use
  • Headache / etiology
  • Headache / physiopathology
  • Humans
  • Hypertension / complications
  • Hypesthesia / etiology
  • Hypesthesia / physiopathology
  • Immunoglobulins, Intravenous / therapeutic use
  • Immunologic Factors / therapeutic use
  • Irritable Mood
  • Magnetic Resonance Imaging
  • Methylprednisolone / therapeutic use
  • Middle Aged
  • Monoclonal Gammopathy of Undetermined Significance / complications
  • Olfaction Disorders / etiology
  • Olfaction Disorders / physiopathology
  • Pandemics
  • Pneumonia, Viral / complications*
  • Prednisone / therapeutic use
  • Pupil Disorders / etiology
  • Pupil Disorders / physiopathology
  • Reflex, Abnormal
  • Spinal Cord / diagnostic imaging
  • Vision Disorders / etiology
  • Vision Disorders / physiopathology
  • Visual Field Tests

Substances

  • Glucocorticoids
  • Immunoglobulins, Intravenous
  • Immunologic Factors
  • Prednisone
  • Methylprednisolone